Cell Genesys Company Profile

10:57 EDT 19th March 2019 | BioPortfolio

Cell Genesys is a leader in the development and commercialization of innovative therapeutic products for cancer based on gene therapy technologies. The company has a broad portfolio of clinical stage product development programs, the largest patent portfolio in the gene therapy field, proprietary gene delivery technologies, and a strong balance sheet, all of which have helped position Cell Genesys as a leader in gene therapy. The company is conducting clinical trials in multiple types of cancer utilizing two of its three product platform technologies--GVAX® cancer vaccines and oncolytic virus therapies. Cell Genesys' gene therapy technologies, the company's third product platform, are being evaluated in preclinical programs for multiple types of cancer. The company's majority-owned subsidiary, Ceregene, Inc., is focused on the development of gene therapies for neurologic disorders. Cell Genesys also continues to hold approximately nine million shares of common stock in its former subsidiary, Abgenix, Inc.


United States of America


Phone: 650.266.3000
Fax: 650.266.3010

News Articles [1305 Associated News Articles listed on BioPortfolio]

Cell Genesys Earns $4.5 Million Payment from GVAX Cancer Vaccine Collaboration

Cell Genesys Inc. (Foster City, CA) announced on July 1 that it has earned a $4.5 million payment following the completion of an initial Phase I/II clinical trial of GVAX prostate cancer vaccine...

Cold Genesys studies NMIBC candidate in combo with Merck's Keytruda

Cold Genesys Inc. entered a trial collaboration with Merck & Co. Inc. to study Merck’s Keytruda (pembrolizumab) in combination with Cold Genesys’ CG0070 for non-muscle invasive bladder cancer pati...

Genesys Spine's AIS-C Stand-Alone System cleared by FDA

The FDA has granted Genesys Spine clearance to market its AIS-C Stand-Alone System, which provides nonscrew-based, direct-ant -More- 

Cold Genesys raises $22mm in Series C round

Cold Genesys Inc. (oncolytic immunotherapies for solid tumors) raised $22mm through its Series C round from investors including ORI Healthcare Fund (lead) and Perseverance Capital Management. The comp...

Cold Genesys Announces Clinical Trial Collaboration to Evaluate the Combination of CG0070 and KEYTRUDA® (pembrolizumab) in Bladder Cancer

Cold Genesys, Inc. today announced that it has entered into a clinical collaboration with Merck (known as MSD outside the United States and Canada) to evaluate the combination of ...

Cold Genesys Closes $22 Million Series C Financing

Investment to Advance Clinical Development of Oncolytic Immunotherapies in Bladder Cancer and other Solid Tumors Cold Genesys, Inc., a clinical-stage biopharmaceutical ...

Cold Genesys secures $22M Series C round for oncolytic virus in bladder cancer

The company’s lead product candidate, CG0070, has completed a Phase II study and will be tested in another trial, combined with Merck&#

Cold Genesys Announces New Leadership Appointments

- - Leonard Post, Ph.D, Former Board Member of Viralytics and BioVex, Joins Cold Genesys as Board Member - - - - James Mulé, Ph.D., Associate Center Director of Moffitt ...

Drugs and Medications [0 Results]


PubMed Articles [2587 Associated PubMed Articles listed on BioPortfolio]

Oriented Cell Division: The Pull of the Pole.

Cells are thought to divide along their longest axis. Now, two studies in Developmental Cell (Scarpa et al., 2018) and EMBO Journal (Finegan et al., 2018) reveal that in many instances, cell divisio...

Let curiosity lead you.

It is an incredible honor to receive the Woman in Cell Biology Mid-Career Award for Excellence in Research. My lab works on cell-cell fusion, an indispensable process in the conception, development, a...

Roles of ubiquitin in autophagy and cell death.

The balance between cell survival and cell death is often lost in human pathologies such as inflammation and cancer. Autophagy plays a critical role in cell survival: essential nutrients are generated...

Complement C3 and Autophagy Keep the β Cell Alive.

Autophagy prevents pancreatic β cell death during obesity, although the mechanism of autophagy activation in the β cell has remained elusive. In this issue of Cell Metabolism, King et al. (2018) sh...

Cell cycle, cell division, cell death.

Clinical Trials [6738 Associated Clinical Trials listed on BioPortfolio]

Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair

Double blinded, randomized controlled prospective study looking at 2 preoperative doses of Tamsulosin an alpha-adrenergic blocker in preventing post-operative urinary retention. A previous...

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a...

A Study for Patients With Non-Hodgkin's Lymphomas

In this study, all patients will get investigational drug. There will be no comparator drug. This study will evaluate three tumor types: T-cell lymphoma, Indolent B-cell lymphoma, and A...

CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation

The main purpose of this study is to explore the efficacy of CD19-targeted CAR-T cell therapy for minimal residual disease (MRD) in B-cell Malignancies after autologous stem cell transplan...

Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease

To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding o...

Companies [1002 Associated Companies listed on BioPortfolio]

Cell Genesys

Cell Genesys is a leader in the development and commercialization of innovative therapeutic products for cancer based on gene therapy technologies. The company has a broad portfolio of clinical stage...

Cold Genesys, Inc.

Cold Genesys Incorporated is a privately held biopharmaceutical company that is focused on delivering innovative conditionally replicative (Rb pathway defective molecule E2...

Genesys BioLabs

Genesys is a leading provider of customer service and contact center solutions. With more than 2,700 customers in 80 countries, Genesys orchestrates more than 100 million customer...

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive w...

Genesys Capital

With experience in building, managing and providing financing for high technology and biotechnology companies, Genesys Capital Partners has developed a strong business, professional and scientific net...

More Information about "Cell Genesys" on BioPortfolio

We have published hundreds of Cell Genesys news stories on BioPortfolio along with dozens of Cell Genesys Clinical Trials and PubMed Articles about Cell Genesys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Genesys Companies in our database. You can also find out about relevant Cell Genesys Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Corporate Database Quicklinks

Searches Linking to this Company Record